DK2883954T3 - Peptidbibliotek og anvendelse deraf - Google Patents

Peptidbibliotek og anvendelse deraf Download PDF

Info

Publication number
DK2883954T3
DK2883954T3 DK13827389.1T DK13827389T DK2883954T3 DK 2883954 T3 DK2883954 T3 DK 2883954T3 DK 13827389 T DK13827389 T DK 13827389T DK 2883954 T3 DK2883954 T3 DK 2883954T3
Authority
DK
Denmark
Prior art keywords
peptid
library
peptid library
Prior art date
Application number
DK13827389.1T
Other languages
English (en)
Inventor
Daisuke Nishimiya
Ryuji Hashimoto
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of DK2883954T3 publication Critical patent/DK2883954T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1044Preparation or screening of libraries displayed on scaffold proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
DK13827389.1T 2012-08-08 2013-08-07 Peptidbibliotek og anvendelse deraf DK2883954T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012176208 2012-08-08
PCT/JP2013/071345 WO2014024914A1 (ja) 2012-08-08 2013-08-07 ペプチド・ライブラリー及びその利用

Publications (1)

Publication Number Publication Date
DK2883954T3 true DK2883954T3 (da) 2020-09-28

Family

ID=50068137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13827389.1T DK2883954T3 (da) 2012-08-08 2013-08-07 Peptidbibliotek og anvendelse deraf

Country Status (10)

Country Link
US (3) US10550154B2 (da)
EP (2) EP3748001A1 (da)
JP (6) JP6441075B2 (da)
AU (1) AU2013300549B2 (da)
CA (1) CA2881431C (da)
DK (1) DK2883954T3 (da)
ES (1) ES2813867T3 (da)
IL (1) IL237135B (da)
TW (1) TW201410709A (da)
WO (1) WO2014024914A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101744959B1 (ko) * 2014-12-05 2017-06-12 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
ES2966319T3 (es) * 2016-12-22 2024-04-19 Daiichi Sankyo Co Ltd Péptido para el tratamiento de la degeneración macular asociada con la edad
DE102017114737A1 (de) * 2017-06-30 2019-01-03 Immatics Biotechnologies Gmbh Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
EP3656861A4 (en) 2017-07-18 2021-04-07 Daiichi Sankyo Company, Limited ACTIVE MMP9-BINDING PEPTIDE
CA3075251A1 (en) 2017-09-07 2019-03-14 Daisuke Nishimiya Peptides inhibiting klk1, klk4, or klk4 and klk8
TW202015718A (zh) * 2018-06-21 2020-05-01 日商第一三共股份有限公司 視網膜色素變性治療用胜肽
TW202038997A (zh) 2018-11-07 2020-11-01 日商第一三共股份有限公司 胜肽之血中動態改善方法
BR112021008989A2 (pt) * 2018-11-07 2021-08-17 Daiichi Sankyo Company, Limited peptídeo inibidor de klk5
JP7202696B2 (ja) * 2021-03-05 2023-01-12 株式会社ユニバーサルエンターテインメント 遊技機
JP7202695B2 (ja) * 2021-03-05 2023-01-12 株式会社ユニバーサルエンターテインメント 遊技機

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233697T2 (de) * 1991-03-01 2008-01-24 Dyax Corp., Cambridge Verfahren zur Entwicklung von bindenden Mikroproteinen
ATE529444T1 (de) * 1994-01-11 2011-11-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
CA2512590A1 (en) 2003-01-07 2004-07-29 Dyax Corporation Kunitz domain library
EP1640020A1 (en) * 2003-05-13 2006-03-29 Mizuo Miyazaki Cardioprotective agent
JP2008545399A (ja) * 2005-05-18 2008-12-18 ワイス 白血病疾患遺伝子およびその使用
AU2006294644A1 (en) * 2005-09-27 2007-04-05 Amunix, Inc. Proteinaceous pharmaceuticals and uses thereof
WO2009093119A2 (en) * 2008-01-21 2009-07-30 Med Discovery S.A. Use of serine protease inhibitors in the treatment of skin diseases

Also Published As

Publication number Publication date
AU2013300549A1 (en) 2015-03-19
US11319345B2 (en) 2022-05-03
US20220372076A1 (en) 2022-11-24
US20150197546A1 (en) 2015-07-16
EP3748001A1 (en) 2020-12-09
JP6790212B2 (ja) 2020-11-25
TW201410709A (zh) 2014-03-16
JPWO2014024914A1 (ja) 2016-07-25
JP2019073510A (ja) 2019-05-16
JP2020023531A (ja) 2020-02-13
US10550154B2 (en) 2020-02-04
CA2881431A1 (en) 2014-02-13
AU2013300549B2 (en) 2019-04-11
JP6441075B2 (ja) 2018-12-19
CA2881431C (en) 2021-10-19
JP7203800B2 (ja) 2023-01-13
EP2883954B1 (en) 2020-07-08
JP2021035383A (ja) 2021-03-04
JP2024038496A (ja) 2024-03-19
ES2813867T3 (es) 2021-03-25
US20200199179A1 (en) 2020-06-25
EP2883954A1 (en) 2015-06-17
IL237135B (en) 2019-08-29
JP7429765B2 (ja) 2024-02-08
WO2014024914A1 (ja) 2014-02-13
IL237135A0 (en) 2015-04-30
EP2883954A4 (en) 2016-03-02
JP6603390B2 (ja) 2019-11-06
JP2023027398A (ja) 2023-03-01

Similar Documents

Publication Publication Date Title
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
DK3043784T3 (da) Arylethere og anvendelser deraf
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
DK2850202T3 (da) Fremgangsmåder og grupper
DK3381917T3 (da) Imidazopyridinforbindelser og anvendelser deraf
DK2920167T3 (da) Hydrazinyl-indol-forbindelser og konjugater
DK2906684T3 (da) T-celle-modificerende forbindelser og anvendelser deraf
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
DK2968443T3 (da) Hepcidinanaloger og anvendelser deraf
DK2914291T3 (da) Anti-komplement-c1s-antistoffer og anvendelser deraf
DK2854883T3 (da) Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
DK2922877T3 (da) Forbedrede peptidlægemidler
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK2883954T3 (da) Peptidbibliotek og anvendelse deraf
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK2552434T3 (da) Peptider og anvendelse deraf
BR112014031384A2 (pt) métodos e sistemas
DK3003117T3 (da) Videolaryngoskop og laryngoskopindføringsdel
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf